Title |
Toluene has antidepressant-like actions in two animal models used for the screening of antidepressant drugs
|
---|---|
Published in |
Psychopharmacology, January 2009
|
DOI | 10.1007/s00213-009-1462-2 |
Pubmed ID | |
Authors |
Silvia L. Cruz, Paulina Soberanes-Chávez, Nayeli Páez-Martinez, Carolina López-Rubalcava |
Abstract |
Many abused solvents share a profile of effects with classical antidepressants. For example, toluene, which is a representative and widely abused solvent, has been reported to increase both serotonin and noradrenaline levels in several brain areas after an acute exposure and to act as a noncompetitive antagonist of the glutamatergic N-methyl-D-aspartic acid (NMDA) receptor subtype. Therefore, it is possible that toluene could possess antidepressant-like actions. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 66 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Spain | 1 | 2% |
Unknown | 64 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 15 | 23% |
Student > Ph. D. Student | 13 | 20% |
Student > Doctoral Student | 8 | 12% |
Researcher | 7 | 11% |
Student > Master | 5 | 8% |
Other | 9 | 14% |
Unknown | 9 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 15 | 23% |
Agricultural and Biological Sciences | 10 | 15% |
Medicine and Dentistry | 9 | 14% |
Psychology | 5 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
Other | 12 | 18% |
Unknown | 12 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2017.
All research outputs
#7,219,910
of 25,027,251 outputs
Outputs from Psychopharmacology
#1,995
of 5,590 outputs
Outputs of similar age
#45,950
of 185,488 outputs
Outputs of similar age from Psychopharmacology
#12
of 28 outputs
Altmetric has tracked 25,027,251 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 5,590 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 185,488 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.